Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0017636 (
glioblastoma
)
18,345
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Glioblastoma
is the most common primary malignancy of the adult central nervous system and is associated with a markedly poor prognosis. Elucidating the pathogenesis and molecular changes will assist in further understanding the pathogenesis and progression of the disease and offer novel targets for therapies. The present study demonstrated that the expression level of
GK5
was lower in high-grade
glioblastoma
tissues compared with low-grade ones and it can promote proliferation in
glioblastoma
cells. The regulatory mechanism of
GK5
in
glioblastoma
were also investigated. It was revealed that
GK5
is a target of miR-135b in U87MG
glioblastoma
cells. Controry to
GK5
, the expression of miR-135b is upregulated in
glioblastoma
and its expression is positively associated with the grade of the disease. Finally, it was demonstrated that miR-135b promoted the proliferation of U87MG cells. Therefore, miR-135b may function as an oncogene by inhibiting
GK5
in
glioblastoma
.
...
PMID:MicroRNA-135b exerts oncogenic activity in glioblastoma via the inhibition of glycerol kinase 5 expression. 2593 94